Sort
16,179 grants matching “malaria”
Defining correlates of protection from dengue illness in a long-term cohort study of multigenerational house-holds in Thailand
$710,711Kathryn B Anderson · Upstate Medical University · R01 · FY2023 · AI
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives
$710,593Jonathan J Juliano · Univ Of North Carolina Chapel Hill · R01 · FY2019 · AI
Structure and function of the Plasmodium myosin XIV-actin glideosome
$710,260Kathleen M Trybus · University Of Vermont & St Agric College · R01 · FY2018 · AI
Structure and function of the Plasmodium myosin XIV-actin glideosome
$710,260Kathleen M Trybus · University Of Vermont & St Agric College · R01 · FY2021 · AI
Structure and function of the Plasmodium myosin XIV-actin glideosome
$710,260Kathleen M Trybus · University Of Vermont & St Agric College · R01 · FY2020 · AI
Structure and function of the Plasmodium myosin XIV-actin glideosome
$710,260Kathleen M Trybus · University Of Vermont & St Agric College · R01 · FY2019 · AI
Use of forward Genetic approaches to identify Babesia receptors
$710,081Cheryl Ann Lobo · New York Blood Center · R01 · FY2021 · HL
Production and purification of biological compounds
$710,051Joseph Shiloach · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2019 · DK
Optimization of antimalarials targeting multiple life stages of the parasite
$709,897Paul R Carlier · University Of Illinois At Chicago · R01 · FY2024 · AI
Molecular basis of antimalarial drug resistance in Plasmodium vivax
$709,754Manoj T Duraisingh · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2025 · AI
The Long-Acting/Extended Release Antiretroviral Resource Program (LEAP)
$709,629Charles W. Flexner · Johns Hopkins University · R24 · FY2021 · AI
Madagascar P. vivax Invasion of Duffy-negative Red Cells
$709,536Peter A. Zimmerman · Case Western Reserve University · R01 · FY2014 · AI
BIODIVERSITY CONSERVATION & DRUG DISCOVERY IN MADAGASCAR
$709,383David G Kingston · Virginia Polytechnic Inst And St Univ · U01 · FY2006 · TW
ALABAMA/ZAMBIA HIV VACCINE CLINICAL TRIALS UNIT (HVTU)
$709,372Paul A. Goepfert · University Of Alabama At Birmingham · U01 · FY2006 · AI
Spatio-temporal data integration methods for infectious disease surveillance
$709,208Justin V Remais · University Of California Berkeley · R01 · FY2019 · AI
Malaria transmission blocking through mosquito contact with treated surfaces
$708,809Flaminia Catteruccia · Harvard School Of Public Health · R01 · FY2023 · AI
Innate Immune Activation in Malaria
$708,793Douglas T. Golenbock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2015 · AI
Innate Immune Activation in Malaria
$708,793Douglas T. Golenbock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · AI
Innate Immune Activation in Malaria
$708,793Douglas T. Golenbock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2014 · AI
Innate Immune Activation in Malaria
$708,793Douglas T. Golenbock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2018 · AI
Innate Immune Activation in Malaria
$708,793Douglas T. Golenbock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2016 · AI
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives
$708,641Jonathan J Juliano · Univ Of North Carolina Chapel Hill · R01 · FY2021 · AI
Orally Bioavailable 4(1H)-Quinolones with Multi-Stage Antimalarial Activity
$708,550Roman Manetsch · Northeastern University · R01 · FY2022 · AI
Identifying the targets of protective immunity to severe falciparum malaria
$708,202Jonathan D. Kurtis · Brown University · R01 · FY2025 · AI
Madagascar P. vivax Invasion of Duffy-negative Red Cells
$708,141Peter A. Zimmerman · Case Western Reserve University · R01 · FY2016 · AI